CRISPR
Trade CRISPR 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CRSP Key Statistics
Stock Snapshot
The current CRISPR(CRSP) stock price is $60.43, with a market capitalization of 5.93B. The stock trades at a price-to-earnings (P/E) ratio of -9.48.
On 2026-02-26, CRISPR(CRSP) stock moved within a range of $53.75 to $61.76. With shares now at $60.43, the stock is trading +12.4% above its intraday low and -2.2% below the session's peak.
Trading volume for CRISPR(CRSP) stock has reached 3.66M, versus its average volume of 1.71M.
The stock's 52-week range extends from a low of $30.04 to a high of $78.48.
The stock's 52-week range extends from a low of $30.04 to a high of $78.48.
CRSP News
CRISPR Therapeutics AG (NASDAQ:CRSP) shares jumped on Thursday, building on its Feb. 13 earnings report that showed growing momentum for its lead gene therapy a...
Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options become available this week, for the October 16th expiration. One of the key inputs that goes...
Analyst ratings
57%
of 28 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.